[Mortality in patients hospitalized with COVID-19 in northern Peru]

Franco León-Jiménez1, Camila Vives-Kufoy2, Virgilio E Failoc-Rojas3

  • 1Departamento Medicina Interna, Hospital Santa Rosa Piura, Piura, Perú.

Revista Medica De Chile
|March 23, 2022
PubMed

Insights

In Peru, over half of moderate to severe COVID-19 patients studied died. Older age, rapid disease progression, comorbidities, and specific lab results like neutrophilia were linked to higher mortality risks.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • Peru faced exceptionally high COVID-19 mortality rates globally.
  • Understanding risk factors for severe COVID-19 is crucial for patient outcomes.

Purpose of the Study:

  • To detail the clinical presentation and progression of COVID-19 in Peruvian patients.
  • To identify factors associated with mortality in moderate to severe COVID-19 cases.

Main Methods:

  • A prospective analytical study was conducted.
  • Clinical, laboratory, imaging, and mortality data were collected from 391 hospitalized patients.
  • Data was gathered over a two-month period during the initial pandemic wave.

Main Results:

  • The median age of patients was 60 years, with 70% being women.
  • Common findings included neutrophilia (78%) and ground-glass opacities on imaging (91%).
  • A high mortality rate of 53% was observed, with 50% of all patients dying.

Conclusions:

  • Mortality in this cohort was substantial, with over half of the patients succumbing to the disease.
  • Key factors associated with increased mortality included advanced age, rapid disease progression, presence of comorbidities, lymphopenia, neutrophilia, and a low PaO2/FiO2 ratio.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
495
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
476
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
410
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
370
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
376
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
82